Circulating immune checkpoints predict heart failure outcomes
Abstract Aims There are limited data examining the role of immune checkpoint (IC) ligands in the pathophysiology of heart failure (HF). Therefore, we explore this in three HF animal models and in three different human cohorts (healthy, stable, and worsening HF). Methods and results Transcriptomic an...
Auteurs principaux: | Elles M. Screever, Laura I.E. Yousif, Javid J. Moslehi, Joe‐Elie Salem, Adriaan A. Voors, Herman H.W. Silljé, Rudolf A. deBoer, Wouter C. Meijers |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Wiley
2023-08-01
|
Collection: | ESC Heart Failure |
Sujets: | |
Accès en ligne: | https://doi.org/10.1002/ehf2.14304 |
Documents similaires
-
Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
par: Douglas B. Johnson, et autres
Publié: (2019-05-01) -
Checkpoint Inhibition in Myeloma: Opportunities and Challenges
par: Federica Costa, et autres
Publié: (2018-09-01) -
The role of immune checkpoints in cardiovascular disease
par: Laura I. Yousif, et autres
Publié: (2022-10-01) -
Enhancing cancer care with improved checkpoint inhibitors
par: Vickram A S, et autres
Publié: (2024-10-01) -
Checkmate with checkpoint inhibitors: New paradigm in immunotherapy
par: Ruby Dhar, et autres
Publié: (2023-04-01)